Back to search

The Open University

Cellular TRIM33 ubiquitin ligase restricts HIV-1 infection by targeting viral integrase

Abstract

dc:description.abstract

Human Immunodeficiency virus-1 Integrase (HIV-1IN) is essential for the virus life cycle since it catalyzes the integration of the viral genome into the host cell chromosomes. Integrated viral genome provides a favorable niche for gene expression and can become latent and further unrecognizable by antiviral drugs. During an early phase of infection, the host ubiquitin-proteasome machinery senses the IN protein and selectively degrades it in order to block the viral cDNA integration. HIV-1 is an obligatory parasite, which uses diverse host cellular machineries and host factors to protect or hide IN from host ubiquitin-proteasome, as well as the host enzymes that positively regulate IN stability. It is well established that the host ubiquitin-proteasome plays an inhibitory role in the early stage of replication by selectively degrading incoming viral proteins (including IN); however, the cellular factors that are responsible for IN ubiquitin-mediated degradation remain still undefined. Study of the cellular factors that mediate IN degradation during the early stages of viral replication might be a valuable tool in discovering novel targets for AIDS drug development. In this thesis, we describe and characterize a cellular factor, TRIM33, which selectively targets IN for ubiquitin-proteasome mediated degradation. TRIM33 was identified as IN destabilizing factor in high throughput screening, based on high-content fluorescent microscopy, using a library of ~600 siRNAs against factors in the ubiquitin-conjugation pathway. It belongs to a large family of TRIM proteins, which harbor antiviral activities against different viruses. TRIM33 has also been shown to regulate the stability of cellular proteins in an ubiquitin-proteasome dependent manner. We show here that TRIM33 acts as a novel IN ubiquitin E3-ligase, and that its RING domain is essential for ubiquitin E3 ligase activity. It interacts physically with IN inside the nucleus, with the C-terminal domain of IN and the TRIM domain of the TRIM33 being involved in IN-TRIM33 interaction. The silencing of TRIM33 protein increased HIV-1 integration in primary CD4+ T cells and the lymphoid SupT1 cell line. Most interestingly, knockdown of the TRIM33 reverted the phenotype of the mutant virus (IN S57A) carrying a destabilizing point mutation in the IN protein. In conclusion, the newly discovered cellular TRIM33 is a novel restriction factor for HIV-1 infection, which acts by targeting viral integrase protein for degradation through the ubiquitin-proteasome pathway

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
The Open University
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ali, Hashim

Rights

Language dc:language
en

Chain of custody

source
Harvested from
The Open University
Base URL
oro.open.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ali, Hashim. Cellular TRIM33 ubiquitin ligase restricts HIV-1 infection by targeting viral integrase. doctoral thesis, The Open University, 2015.